Measuring biotherapeutics with endogenous counterparts and pre-existing antibodies: An interferon case study

Bioanalysis

Volumn 6, Issue 8, 2014, Pages 1113-1122

  Myler, Heather ^a   Felix, Tonya ^b   Zhu, Jie ^c   Hruska, Matt ^a   Piccoli, Steven P ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Tandem Labs   (United States)

^c WUXI APPTEC   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL PRODUCT; DRUG ANTIBODY; INTERFERON; INTERFERON LAMBDA; UNCLASSIFIED DRUG; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BINDING ASSAY; CASE STUDY; CHINA; CONTROLLED STUDY; DRUG DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; LIGAND BINDING; MAJOR CLINICAL STUDY; PHARMACOKINETICS; SERUM; UNITED STATES; VALIDATION STUDY; BLOOD; CHEMISTRY; IMMUNOLOGY; PROCEDURES; REPRODUCIBILITY;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOASSAY; INTERLEUKINS; REPRODUCIBILITY OF RESULTS;

EID: 84901021485     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.37     Document Type: Article

References (10)

1. Findlay JWA, Smith WC, Lee JW et al. Validation of immunoassays for bioanalysis: A pharmaceutical industry perspective. J. Pharm. Biomed. Anal. 21, 1249-1273 (2000
2. DeSilva B, Smith W, Weiner R et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20(11), 1885-1900 (2003
3. Smolec J, DeSliva B, Smith W et al. Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. Pharm. Res. 22(9), 1425-1431 (2005
4. Kelley M, DeSilva B. Key elements of bioanalytical method validation for macromolecules. AAPS J. 9(2), E156-E163 (2007
5. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation. FDA, Rockville, MD, USA (2001
6. European Medicines Agency. Guideline on Bioanalytical Method Validation. European Medicines Agency, London, UK (2011
7. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research. Draft Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins. FDA, Rockville, MD, USA (2009
8. Myler HA, McVay S, Kratzsch J. Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients. J. Pharm. Toxicol. Methods 61, 92-97 (2010
9. Lee J, Kelley M, King L et al. Bioanalytical Approaches to quantify total and free therapeutic antibodies and their targets: Technical challenges and PK/PD applications over the course of drug development. AAPSJ. 13(1), 99-110 (2011
10. Myler H, Given A, Kolz K et al. Biotherapeutic bioanalysis: A multi-indication case study review. Bioanalysis 3(6), 623-624 (2011